Astrana Health, Inc. (ASTH) research
Astrana Health, Inc.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $35.88
- As of
Astrana Health, Inc. (ASTH): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-23.
As of . Source: SEC EDGAR filings for ASTH. Method and limitations.
Share the ASTH intelligence card
See the full ASTH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ASTH on one page. Preview it with sample data, then open it live with a free account.
Preview the ASTH dossierActive signals for ASTH
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +1122% to ASTH (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 16.6%, EPS $0.40 vs $0.3431 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 48.7% - EPS $0.19 vs $0.3704 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 97.8% - EPS $0.01 vs $0.4501 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 11.0% - EPS $0.12 vs $0.1081 estimate
FREE, NO ACCOUNT
Every signal on ASTH, as it fires
New filings, 13F moves and cross asset signals on ASTH land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ASTH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 03763A207 · 2026Q2 | $8.8M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 03763A207 · 2026Q2 | $3.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 03763A207 · 2026Q2 | $1.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ASTH
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ASTH against its peers
ASTH's operating margin of 2.5% ranks in the 50th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | ASTH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.2B USD | 1.4B USD | 75 | 17 |
| Gross margin | n/a | 23.0% | n/a | 5 |
| Operating margin | 2.5% | 3.4% | 50 | 16 |
| Net margin | 0.7% | 2.8% | 45 | 18 |
| Return on equity | 2.9% | 8.8% | 41 | 15 |
| P / E | 78.0x | 21.3x | 85 | 9 |
Peers (18): SNDA, SGRY, ARDT, NUTX, ADUS, AGL, INNV, GRDN, NHC, LFST, CON, TOI, MCTA, SRTA, CYH, FMS, AIRS, JYNT. Left out: LTGHY (no annual filing), BUHPY (no annual filing), GMRS (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing), FSNUY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ASTH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ASTH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ASTHand get the insider, 13F, options, and confluence read in one view.